Vesiflo Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $87.5K
Latest Deal Amount
  • Investors
  • 1

Vesiflo General Information

Description

Developer of a non-surgical urinary prosthesis designed for women with permanent urinary retention due to impaired detrusor contractility. The company's device mimics normal urination, providing a convenient and dignified alternative to urinary catheters, allowing women with IDC to urinate, without the need to catheterize daily or be attached to a urine drainage bag.

Contact Information

Website
www.vesiflo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 8531 154th Avenue, North East
  • Suite 150
  • Redmond, WA 98052
  • United States
+1 (425) 000-0000

Vesiflo Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vesiflo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 03-Mar-2021 $87.5K 00.000 Completed Generating Revenue
2. Later Stage VC 09-May-2019 00000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 19-May-2017 $3.3M $3.3M 00.00 Completed Generating Revenue
To view Vesiflo’s complete valuation and funding history, request access »

Vesiflo Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00 00.000
To view Vesiflo’s complete cap table history, request access »

Vesiflo Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a non-surgical urinary prosthesis designed for women with permanent urinary retention due to impaired detru
Therapeutic Devices
Redmond, WA
2 As of 2019
00.000
0000000000 0 00.000

000000

rure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteu
00000000000 0000000
Eagan, MN
0000
000000000 - 0000

00000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
00000000000 0000000
Seattle, WA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vesiflo Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardia Angel-Backed Eagan, MN 0000 000000000 - 0000
0000000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Leeds, United Kingdom 0 000.00 000000&0 000.00
000000 0000000 Private Equity-Backed Raleigh, NC 00 00000 0000000000.
To view Vesiflo’s complete competitors history, request access »

Vesiflo Patents

Vesiflo Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-9839373-B2 System and method for collecting clinical data associated with a medical apparatus including an implantable device Active 14-May-2015 000000000 00
US-20160331311-A1 System and method for collecting clinical data associated with a medical apparatus including an implantable device Granted 14-May-2015 0000000000
US-20160331509-A1 System and method for collecting clinical data associated with a medical apparatus including an implantable device Granted 14-May-2015 000000000 0
US-10238314-B2 System and method for collecting clinical data associated with a medical apparatus including an implantable device Active 14-May-2015 000000000 00
US-20190117116-A1 System and method for collecting clinical data associated with a medical apparatus including an implantable device Pending 14-May-2015 A61B5/076
To view Vesiflo’s complete patent history, request access »

Vesiflo Executive Team (4)

Name Title Board Seat Contact Info
Kevin Connolly Founder, President, Chief Executive Officer & Board Member
John Sullivan Acting Chief Financial Officer
Susan Robinson Chief Operating Officer
Thomas Van Noy Senior Director
To view Vesiflo’s complete executive team members history, request access »

Vesiflo Board Members (2)

Name Representing Role Since
Kevin Connolly Vesiflo Founder, President, Chief Executive Officer & Board Member 000 0000
Wayne De Meester Self Board Member 000 0000
To view Vesiflo’s complete board members history, request access »

Vesiflo Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vesiflo Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boston Angel Club Angel Group Minority 000 0000 000000 0
To view Vesiflo’s complete investors history, request access »